Literature DB >> 11907851

Are cutaneous reactions to fly larvae mediated by CD4+, TIA+ NK1.1 T Cells?

C Norwood1, K J Smith, R Neafie, H Skelton.   

Abstract

BACKGROUND: Although there have been reports of fly larvae in wounds and as isolated primary infestations, there have been only rare reports documenting reactions to the larvae within the skin in humans and animals. There have been no reports documenting the histopathologic and immunohistochemical characteristics of the inflammatory infiltrate.
OBJECTIVE: We present a patient who developed local pruritus, erythema, and swelling approximately three weeks after infestation by a fly larva within the scalp. Histopathologically the biopsy site showed a mixed infiltrate containing lymphoid cells and numerous eosinophils. Immunohistochemical stains showed predominantly CD4+ T cells expressing an ab T-cell receptor (TCR) of which approximately 30% coexpressed T-cell intracellular antigen (TIA) and CD56. In addition, there were approximately 5% of these CD4+ T cells which coexpressed CD30.
CONCLUSIONS: Histopathologic and immunohistochemical findings are consistent with an effector cell population of cytotoxic CD4+ T cells that produce a T-helper 2 cytokine pattern. The phenotype of this subset of T cells is unique and among its characteristics is that antigens--usually nonprotein antigens--are presented to these CD4+,TIA+ natural killer (NK)1.1T cells by CD1d molecules.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11907851     DOI: 10.1007/s10227-001-0009-x

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  2 in total

1.  Expression of CD1d in human scalp skin and hair follicles: hair cycle related alterations.

Authors:  M A Adly; M A Adley; H A Assaf; M Hussein
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

2.  Ectoparasitic infestations.

Authors:  Jörg Heukelbach; Shelley F Walton; Hermann Feldmeier
Journal:  Curr Infect Dis Rep       Date:  2005-09       Impact factor: 3.725

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.